UHLMANN PRICE SECURITIES, LLC
Broker-DealerPosition in BMY — Bristol Myers Squibb Co
CIK 1035344
SKOKIE, IL
Position in BMY
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$989,277
+$28,521 QoQ
Shares Held
17,169
+8.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,170
of 2,506 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026UHLMANN PRICE SECURITIES, LLC holds $16,788,267 across 9 Drug Manufacturers - General names. BMY ranks #5 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,508 | $5,407,030 | |
| 2 | JNJ |
Johnson & Johnson
|
13,885 | $3,526,373 | |
| 3 | ABBV |
AbbVie Inc.
|
12,593 | $3,168,902 | |
| 4 | MRK |
Merck & Co., Inc.
|
13,592 | $1,746,571 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
17,169 | $989,277 | |
| 6 | PFE |
Pfizer Inc
|
37,865 | $911,789 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,994 | $504,601 | |
| 8 | AZN |
Astrazeneca PLC
|
1,751 | $332,024 |
All Filings in BMY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $989,277 | 17,169 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $960,756 | 15,841 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $313,121 | 5,805 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $244,802 | 5,428 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $284,729 | 6,151 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $472,916 | 7,754 | Shares | Sole | 2025-07-17 | |
| 2024-12-31 | $412,152 | 7,287 | Shares | Sole | 2025-07-17 | |
| 2024-09-30 | $376,615 | 7,279 | Shares | Sole | 2025-07-30 | |
| No filing history on record for this holder in this stock. | ||||||